GENEVA, Switzerland -- No individual chronic disease - not angina, not arthritis, not asthma, not diabetes -- is more disabling than depression, according to a World Health Organization study.

SEOUL, South Korea -- Therapies that target several cancer pathways at once, such as multi-kinase inhibitors, might have an emerging role in non-small-cell lung cancer.

OXFORD, England -- None of 10 micronutrients -- such as carotenoids, retinol, and tocopherols -- appears to help prevent prostate cancer, found investigators here.

ATLANTA -- Folate levels in the American diet have declined slightly in the last pew years, but not enough to cause alarm, said CDC investigators.

MINNEAPOLIS -- American military physicians at Guantanamo are acting in ways that seem reminiscent of those of doctors who fronted for the South African apartheid regime a generation ago, alleged 266 doctors and ethicists.

SOUTHAMPTON, England -- As many parents with hyperactive children have long suspected, some artificial food colors and preservatives commonly found in snack foods may wind up some kids, investigators here found.

SEOUL, South Korea -- Erlotinib (Tarceva) is a viable candidate across the board for second-line treatment of non-small-cell lung cancer (NSCLC), oncologists said here.

SEOUL, South Korea --- Thalidomide (Thalomid) apparently can be appended to the long list of failed new strategies for small-cell lung cancer, researchers said here..

SEOUL, South Korea -- Sputum testing for genetic methylation abnormalities may detect half of lung cancers, suggesting it could serve as an inexpensive and noninvasive adjunct for lung cancer screening or diagnosis.

SEOUL, South Korea -- An inhibitor of insulin-like growth factor receptors demonstrated activity in advanced non-small-cell lung cancer, suggesting potential as a new targeted strategy.

DALLAS -- Clues into how autism spectrum disorders work may emerge from mice with a mutation that makes them socially awkward but enhances cognitive abilities.

AMSTERDAM, The Netherlands -- New Internet-capable cell phones can cause life-threatening electrical interference if they're used too close to medical devices, researchers here said.

SEOUL, South Korea -- The lack of long-term survival benefit for current non-small-cell lung cancer drugs continues to drive development of new therapies and new formulations of existing drugs.

NEW HAVEN, Conn. -- Most internal medicine residents had low scores in a test of the biostatistics needed to interpret published clinical research, investigators here found.

SEOUL, South Korea -- Third-generation chemotherapy agents appear to have modestly improved population-level survival among advanced stage non-small-cell lung cancer patients.

SEOUL, South Korea -- Targeted therapy with the receptor tyrosine kinase inhibitor gefitinib (Iressa) demonstrated noninferiority to docetaxel (Taxotere) in treatment of non-small-cell lung cancer in a large multicenter trial.

LEBANON, N.H. -- Epoetin alfa (Epogen or Procrit) failed to reduce red-cell transfusions in ICU patients but appeared to decrease mortality in trauma patients, researchers reported. Still, the drug increased thrombotic events.

VIENNA -- For patients in the early stages of pulmonary arterial hypertension, the use of bosentan (Tracleer) appears to slow the progressive worsening of symptoms.

VIENNA -- Once again a major clinical trial using vitamins to lower homocysteine levels has failed to change clinical outcomes for patients with heart disease.

SEOUL, South Korea -- Pemetrexed (Alimta) may have toxicity advantages over gemcitabine (Gemzar) in first-line combination chemotherapy for advanced non-small cell lung cancer, researchers said here.